Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells.

MERS-CoV cleavage furin protease spike

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: aheadofprint

Résumé

Human-to-human transmission of the highly pathogenic Middle East respiratory syndrome coronavirus (MERS-CoV) is currently inefficient. However, there is concern that the virus might mutate and thereby increase its transmissibility and thus pandemic potential. The pandemic SARS-CoV-2 depends on a highly cleavable furin motif at the S1/S2 site of the viral spike (S) protein for efficient lung cell entry, transmission, and pathogenicity. Here, by employing pseudotyped particles, we investigated whether augmented cleavage at the S1/S2 site also increases MERS-CoV entry into Calu-3 human lung cells. We report that polymorphism T746K at the S1/S2 cleavage site or optimization of the furin motif increases S protein cleavage but not lung cell entry. These findings suggest that, unlike what has been reported for SARS-CoV-2, a highly cleavable S1/S2 site might not augment MERS-CoV infectivity for human lung cells.IMPORTANCEThe highly cleavable furin motif in the spike protein is required for robust lung cell entry, transmission, and pathogenicity of SARS-CoV-2. In contrast, it is unknown whether optimization of the furin motif in the spike protein of the pre-pandemic MERS-CoV increases lung cell entry and allows for robust human-human transmission. The present study indicates that this might not be the case. Thus, neither a naturally occurring polymorphism that increased MERS-CoV spike protein cleavage nor artificial optimization of the cleavage site allowed for increased spike-protein-driven entry into Calu-3 human lung cells.

Identifiants

pubmed: 39470207
doi: 10.1128/jvi.01305-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0130524

Auteurs

Markus Hoffmann (M)

Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.

Hannah Kleine-Weber (H)

Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.

Luise Graichen (L)

Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.

Inga Nehlmeier (I)

Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.

Amy Kempf (A)

Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.

Anna-Sophie Moldenhauer (A-S)

Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.

Elisabeth Braun (E)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Abdullah M Assiri (AM)

Preventive Health, Ministry of Health, Riyadh, Saudi Arabia.

Frank Kirchhoff (F)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Daniel Sauter (D)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.

Khaled R Alkharsah (KR)

Department of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University (IAU), Dammam, Saudi Arabia.

Stefan Pöhlmann (S)

Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.

Classifications MeSH